drugset / Trial / NCT00208949

A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF

NCT00208949 ↗

Phase 2 Terminated 50 enrolled Emory University
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a study involving patients who are undergoing allogeneic peripheral blood stem cell transplantation. Both donors and recipients are being sought for this study.

Timeline

Start
2002-09
Primary completion
2010-05
Completion
2012-05

Outcome

Outcome not reported

Stopped (Enrollment): “slow accrual”

Drugs

EvaluationDrugModalityDoseRoute
Comparator G-CSF Unknown 7.5 ug/kg Subcutaneous
Comparator GM-CSF Protein / enzyme biologic 7.5 ug/kg Subcutaneous

Indications